Annalyse Treat v. HHS - Influenza, Guillain-Barre Syndrome (GBS) (2024)
Case summary [AI summaries can sometimes make mistakes]
Annalyse Treat filed a petition on July 8, 2022, alleging that the influenza vaccine she received on September 19, 2019, caused her to develop Guillain-Barre Syndrome (GBS) and suffer residual effects for more than six months. The influenza vaccine is listed on the Vaccine Injury Table.
Respondent denied that the flu vaccine caused GBS or any other injury. Despite the denial, the parties filed a joint stipulation to resolve the case.
Special Master Christian J. Moran reviewed the stipulation, found it reasonable, and adopted it as the Court's decision.
Ms. Treat was awarded a lump sum of $166,589.92, payable by check to petitioner, as compensation for all damages available under 42 U.S.C. § 300aa-15(a).
This award was made on August 30, 2024, concluding the case. Petitioner was represented by Leigh Finfer of Muller Brazil, LLP, and Respondent was represented by Lynn Christina Schlie of the United States Department of Justice.
The public decision was issued on August 30, 2024.
Theory of causation
Petitioner Annalyse Treat alleged that the influenza vaccine administered on September 19, 2019, caused Guillain-Barre Syndrome (GBS) and residual effects lasting more than six months. The influenza vaccine is listed on the Vaccine Injury Table, and the petitioner claimed a Table injury. Respondent denied causation. The parties resolved the matter via joint stipulation, which Special Master Christian J. Moran found reasonable and adopted. The stipulation resulted in a lump sum award of $166,589.92 to petitioner. Petitioner was represented by Leigh Finfer (Muller Brazil, LLP), and Respondent by Lynn Christina Schlie (U.S. Department of Justice). The decision was issued on August 30, 2024.
Source PDFs
USCOURTS-cofc-1_22-vv-00748